Revisiting bleomycin from pathophysiology to safe clinical use.
Froudarakis M, Hatzimichael E, Kyriazopoulou L, Lagos K, Pappas P, Tzakos AG, Karavasilis V, Daliani D, Papandreou C, Briasoulis E.
Froudarakis M, et al. Among authors: lagos k.
Crit Rev Oncol Hematol. 2013 Jul;87(1):90-100. doi: 10.1016/j.critrevonc.2012.12.003. Epub 2013 Jan 9.
Crit Rev Oncol Hematol. 2013.
PMID: 23312772
Review.